KR860003514A - How contrast and chemotherapeutic agents deliver encapsulated micelles to human tumors - Google Patents
How contrast and chemotherapeutic agents deliver encapsulated micelles to human tumors Download PDFInfo
- Publication number
- KR860003514A KR860003514A KR1019850007773A KR850007773A KR860003514A KR 860003514 A KR860003514 A KR 860003514A KR 1019850007773 A KR1019850007773 A KR 1019850007773A KR 850007773 A KR850007773 A KR 850007773A KR 860003514 A KR860003514 A KR 860003514A
- Authority
- KR
- South Korea
- Prior art keywords
- tumor
- particles
- chemotherapeutic agent
- phospholipid
- micelles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
- A61K51/1234—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Optics & Photonics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.
제1도는 형액중의 방사성표지를 한 인지질 소포의 정화치(精化値) 및 종양중의 축적의 시간경과를 나타낸 도표임.FIG. 1 is a chart showing the purification of phospholipid vesicles labeled with radiolabels and the time course of accumulation in tumors.
제2도은 감마선 섭동각(角) 상관(PAC) 분광법에 의해 측정된 혈액 및 종양중에 잔존하는 방사성 표지를 한 손상되지 않은 인지질 소포의 백분율을 나타낸 그래프임.FIG. 2 is a graph showing the percentage of intact phospholipid vesicles with radiolabel remaining in the blood and tumors as measured by gamma ray perturbation angle correlation (PAC) spectroscopy.
Claims (22)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/663,503 US5435989A (en) | 1982-03-30 | 1984-10-22 | Method of targeting a specific location in a body |
US663550,663503 | 1984-10-22 | ||
US663,503 | 1984-10-22 | ||
US663,550 | 1984-10-22 | ||
US06/663,550 US5441745A (en) | 1982-03-30 | 1984-10-22 | Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body |
Publications (2)
Publication Number | Publication Date |
---|---|
KR860003514A true KR860003514A (en) | 1986-05-26 |
KR900004802B1 KR900004802B1 (en) | 1990-07-06 |
Family
ID=27098764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850007773A KR900004802B1 (en) | 1984-10-22 | 1985-10-22 | Micellular particles encapsulating imaging and chemotherapeutic agents to turmos in a body |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0179444B1 (en) |
JP (1) | JPH0747533B2 (en) |
KR (1) | KR900004802B1 (en) |
AT (1) | ATE64298T1 (en) |
CA (1) | CA1298548C (en) |
DE (2) | DE19675031I2 (en) |
DK (2) | DK482685D0 (en) |
HK (1) | HK119993A (en) |
IE (1) | IE58659B1 (en) |
LU (1) | LU88811I2 (en) |
NL (1) | NL960020I1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE60901B1 (en) * | 1986-08-21 | 1994-08-24 | Vestar Inc | Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
US5043107A (en) * | 1986-08-21 | 1991-08-27 | Vestar Research, Inc. | Preparation small unilamellar vesicles including polyene antifungal antibiotics |
IL88076A (en) * | 1987-10-28 | 1993-01-14 | Nippon Shinyaku Co Ltd | Fat emulsions as drug carriers |
AU598958B2 (en) | 1987-11-12 | 1990-07-05 | Vestar, Inc. | Improved amphotericin b liposome preparation |
US5648532A (en) * | 1993-06-03 | 1997-07-15 | The Regents Of The University Of California | Compositions for boron neutron capture therapy and methods thereof |
JPH10513466A (en) * | 1995-02-09 | 1998-12-22 | シェリング アクチェンゲゼルシャフト | Liposomes containing contrast agents for visualizing intravascular space |
NO312708B1 (en) * | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioactive liposomes for therapy |
WO2005048987A1 (en) * | 2003-11-21 | 2005-06-02 | Fuji Photo Film Co., Ltd. | Contrast medium comprising liposomes containing hydrophobic chelate compound |
EP1745788A1 (en) * | 2005-07-22 | 2007-01-24 | KTB Tumorforschungsgesellschaft mbH | Acyglycerophospholipids for treating cancer and cachexia |
EP2668961A4 (en) * | 2010-11-19 | 2016-07-06 | Univ Sapporo Medical | Combined pharmaceutical preparation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4310505A (en) * | 1979-11-08 | 1982-01-12 | California Institute Of Technology | Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances |
JPS59122423A (en) * | 1982-12-28 | 1984-07-14 | Green Cross Corp:The | Carcinostatic-containing fatty emulsion |
JPS59163315A (en) * | 1983-03-09 | 1984-09-14 | Mitsui Pharmaceut Inc | Carmofur-containing liposome |
-
1985
- 1985-10-21 IE IE260285A patent/IE58659B1/en not_active IP Right Cessation
- 1985-10-21 CA CA000493488A patent/CA1298548C/en not_active Expired - Lifetime
- 1985-10-21 DK DK482685A patent/DK482685D0/en not_active Application Discontinuation
- 1985-10-22 AT AT85113386T patent/ATE64298T1/en active
- 1985-10-22 DK DK484585A patent/DK167556B1/en active Protection Beyond IP Right Term
- 1985-10-22 KR KR1019850007773A patent/KR900004802B1/en not_active IP Right Cessation
- 1985-10-22 EP EP85113386A patent/EP0179444B1/en not_active Expired - Lifetime
- 1985-10-22 DE DE19675031C patent/DE19675031I2/en active Active
- 1985-10-22 JP JP60236230A patent/JPH0747533B2/en not_active Expired - Lifetime
- 1985-10-22 DE DE8585113386T patent/DE3583204D1/en not_active Expired - Lifetime
- 1985-10-22 LU LU88811C patent/LU88811I2/en unknown
-
1993
- 1993-11-04 HK HK1199/93A patent/HK119993A/en not_active IP Right Cessation
-
1996
- 1996-08-09 NL NL960020C patent/NL960020I1/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE19675031I2 (en) | 2008-04-10 |
HK119993A (en) | 1993-11-12 |
IE58659B1 (en) | 1993-11-03 |
NL960020I1 (en) | 1996-11-01 |
DK484585D0 (en) | 1985-10-22 |
JPH0747533B2 (en) | 1995-05-24 |
EP0179444A3 (en) | 1987-08-12 |
DK167556B1 (en) | 1993-11-22 |
CA1298548C (en) | 1992-04-07 |
EP0179444B1 (en) | 1991-06-12 |
EP0179444A2 (en) | 1986-04-30 |
DK484585A (en) | 1986-04-23 |
IE852602L (en) | 1986-04-22 |
DE3583204D1 (en) | 1991-07-18 |
ATE64298T1 (en) | 1991-06-15 |
DK482685D0 (en) | 1985-10-21 |
LU88811I2 (en) | 1996-11-05 |
KR900004802B1 (en) | 1990-07-06 |
JPS61158932A (en) | 1986-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5019369A (en) | Method of targeting tumors in humans | |
US6177059B1 (en) | GPIb-lipid complex and uses thereof | |
Greig | Optimizing drug delivery to brain tumors | |
JP3210662B2 (en) | Dosage agents achieving increased migration of antibodies through capillary barrier | |
Gabizon et al. | Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies | |
Kabalka et al. | Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: targeted MRI contrast enhancement agents for the liver | |
JP5438317B2 (en) | Novel liposome composition | |
AU656915B2 (en) | Stabilized therapeutic radiopharmaceutical complexes | |
Bao et al. | 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats | |
MXPA97002523A (en) | Agents liposomi | |
Goins et al. | The use of scintigraphic imaging as a tool in the development of liposome formulations | |
JPS6048483B2 (en) | lipid membrane drug delivery | |
KR860003514A (en) | How contrast and chemotherapeutic agents deliver encapsulated micelles to human tumors | |
Tilcock | Imaging tools: liposomal agents for nuclear medicine, computed tomography, magnetic resonance, and ultrasound | |
US5435989A (en) | Method of targeting a specific location in a body | |
Ogihara-Umeda et al. | Optimal radiolabeled liposomes for tumor imaging | |
Phillips et al. | Evaluation of [99mTc] liposomes as lymphoscintigraphic agents: comparison with [99mTc] sulfur colloid and [99mTc] human serum albumin | |
Stevenson et al. | Prolonged hypoglycemic effect in diabetic dogs due to subcutaneous administration of insulin in liposomes | |
IL261221A (en) | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use | |
GOTO et al. | Liposomes Prepared from Synthetic Amphiphiles. I.: Their Technetium Labeling and Stability | |
Klibanov et al. | Targeting of macromolecular carriers and liposomes by antibodies to myosin heavy chain | |
EP0182131B1 (en) | The use of micellular particle for making compositions for targeting tumors in humans | |
AU615184B2 (en) | Method of targeting tumors in humans | |
Davis et al. | The evaluation of parenterally administered emulsion formulations | |
Van As | Optimisation and characterisation of Pheroid® entrapped radio tracer formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20050630 Year of fee payment: 16 |
|
EXPY | Expiration of term |